DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
ProVerum has closed an $80m Series B equity financing round, boosting commercialisation efforts for its ProVee system for benign prostatic hyperplasia (BPH). The funding round was led by MVM Partners, ...
DUBLIN, March 20, 2024 /PRNewswire/ -- ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results